Literature DB >> 10491211

Mutations of CTSK result in pycnodysostosis via a reduction in cathepsin K protein.

N Ho1, A Punturieri, D Wilkin, J Szabo, M Johnson, J Whaley, J Davis, A Clark, S Weiss, C Francomano.   

Abstract

Pycnodyostosis, an autosomal recessive osteosclerosing skeletal disorder, has recently been shown to result from mutations in the cathepsin K gene. Cathepsin K, a lysosomal cysteine protease with an abundant expression in osteoclasts, has been implicated in osteoclast-mediated bone resorption and remodeling. DNA sequence analysis of the cathepsin K gene in a nonconsanguineous family demonstrated compound heterozygozity for mutations in two affected siblings. We have identified a missense mutation with a single base G-->A transition at cDNA nucleotide 236, resulting in conversion of a conserved glycine to a glutamine residue (G79E). The other mutation is an A-->T transition at nucleotide 154, leading to the substitution of a lysine residue by a STOP codon (K52X) predicting premature termination of the precursor cathepsin K polypeptide. Sequencing of genomic and cDNAs from the parents demonstrated that the missense mutation was inherited from the father and the nonsense mutation from the mother. Protein expression in both affected children was virtually absent, while in the parents was reduced by 50-80% compared with controls. The protein studies demonstrate that even significantly reduced cathepsin K levels do not have any phenotypic effect, whereas absent cathepsin K results in pycnodysostosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491211     DOI: 10.1359/jbmr.1999.14.10.1649

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  12 in total

1.  High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K.

Authors:  A F Schilling; C Mülhausen; W Lehmann; R Santer; T Schinke; J M Rueger; M Amling
Journal:  Osteoporos Int       Date:  2007-01-06       Impact factor: 4.507

Review 2.  New treatment modalities in osteoporosis.

Authors:  Ernesto Canalis
Journal:  Endocr Pract       Date:  2010 Sep-Oct       Impact factor: 3.443

3.  Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence.

Authors:  Wei Chen; Shuying Yang; Yoke Abe; Ming Li; Yucheng Wang; Jianzhong Shao; En Li; Yi-Ping Li
Journal:  Hum Mol Genet       Date:  2007-01-08       Impact factor: 6.150

4.  Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases.

Authors:  Lingxin Zhu; Yi Tang; Xiao-Yan Li; Evan T Keller; Jingwen Yang; Jung-Sun Cho; Tamar Y Feinberg; Stephen J Weiss
Journal:  Sci Transl Med       Date:  2020-02-05       Impact factor: 17.956

Review 5.  Inhibition of cathepsin K for treatment of osteoporosis.

Authors:  Steven Boonen; Elizabeth Rosenberg; Frank Claessens; Dirk Vanderschueren; Socrates Papapoulos
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

Review 6.  Novel insights into the coupling of osteoclasts and resorption to bone formation.

Authors:  Margaret M Durdan; Ruth D Azaria; Megan M Weivoda
Journal:  Semin Cell Dev Biol       Date:  2021-10-30       Impact factor: 7.727

Review 7.  Advances in osteoclast biology resulting from the study of osteopetrotic mutations.

Authors:  T Segovia-Silvestre; A V Neutzsky-Wulff; M G Sorensen; C Christiansen; J Bollerslev; M A Karsdal; K Henriksen
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

8.  A child with bone fractures and dysmorphic features: remember of pycnodysostosis and craniosynostosis.

Authors:  Alberto Berenguer; António Pedro Freitas; Gomes Ferreira; José Luis Nunes
Journal:  BMJ Case Rep       Date:  2012-11-21

Review 9.  Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011.

Authors:  Yang Xue; Tao Cai; Songtao Shi; Weiguang Wang; Yanli Zhang; Tianqiu Mao; Xiaohong Duan
Journal:  Orphanet J Rare Dis       Date:  2011-05-10       Impact factor: 4.123

10.  Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages.

Authors:  A Punturieri; S Filippov; E Allen; I Caras; R Murray; V Reddy; S J Weiss
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.